Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @GenomeWeb
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @GenomeWeb
-
GenomeWeb proslijedio/la je Tweet
Biotin interference is a real problem with lab tests. Two months ago,
#FDA issued recommendations for labs on how to deal with it. Now,@_AACC has put out its own guidancehttps://bit.ly/3aaOsn1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
JP Morgan updates from
@QIAGEN@GuardantHealth@BioRad@Hologic and@myriadgenetics https://bit.ly/384cZYN#JPM2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
US Supreme Court Declines to Hear Case on Patent Eligibility of Diagnosticshttps://www.360dx.com/policy-legislation/us-supreme-court-declines-hear-case-patent-eligibility-diagnostics?utm_source=addthis_shares#.XhzYSQkGilE.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At JP Morgan,
@illumina says two new sequencing platforms offer super resolution optics and blue/green SBS chemistry that will enable an increase in throughput and a reduction in operating costs. https://bit.ly/2TrreTL#JPM20Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First data from Beat AML trial presented at
#ASH19 shows promise for germline testing in older AML patientshttps://www.precisiononcologynews.com/cancer/ash-study-germline-testing-identifies-cancer-risk-mutations-vus-older-aml-patients …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
GenomeWeb proslijedio/la je Tweet
Our next SOPHiA Webinar together with
@GenomeWeb, entitled "Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA", will take place on January 28th starting at 11:00AM EST - Register here: https://bit.ly/2qhLwms pic.twitter.com/D5UujdfihO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
#GeneticTesting Challenges in Oncology: False Positive After Testing at Pop-Up Booth with @EllenMatloff @MyGeneCounsel#gcchat#geneticcounseling#patientsafety#genCSM#hereditarycancer#gcchat Via @PrecOncNewshttps://www.precisiononcologynews.com/cancer/genetic-testing-challenges-oncology-false-positive-after-testing-pop-booth …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in helping the
@UBCPsych team study direct-to-consumer genetic testing? Take their survey: https://delongis.psych.ubc.ca/ubc-genetic-connections-study/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
Greater use of genetic testing in cancer care brings with it unanticipated challenges for practitioners.
@MyGeneCounsel and@PrecOncNews have partnered on a new series to shed light on these challenges and foster discussion. Read the first case:https://www.precisiononcologynews.com/cancer/genetic-testing-challenges-oncology-appropriate-clinical-management-brip1-variant-unknown#.XbMSLuhKg2w …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb has a new home! We've been acquired by
@CrainComm - a great family of business journalism brands. We look forward to working with the Crain team to better serve our readers' news and information needs!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A VHA program is making precision oncology a relatively routine part of cancer care for many veteranshttps://www.precisiononcologynews.com/molecular-diagnostics/veterans-health-administration-precision-oncology-program-successfully …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An official from the
@ASCO CancerLinQ database says labs have a responsibility under the 21st Century Cures Act to facilitate integration of genomic data into EHRs.https://www.precisiononcologynews.com/informatics/cancerlinq-calls-mdx-labs-share-structured-genomic-reports-support-precision-oncology …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What is the clinical value of cell-free DNA testing in
#prenatalcare? Professor Nicolaides of King’s College will discuss different implementation models & share his own experience with#cellfreeDNA testing for fetal#aneuploidy during our 7/25 webinar http://bit.ly/2LBWXylHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
Why are molecular assays the smartest choice for
#GroupBStrep screening? Watch the free webinar and find out why when Dr. Pride presents the results of his recent#JCM publication comparing molecular to culture. Register today! https://bit.ly/2EDsACG#JulyIsIntlGBSAwarenessMonthpic.twitter.com/0wuTNixVmy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
#qualityimprovement Improvement Model to Support#Molecular Testing of#Oncology#Patients register http://bit.ly/EPIDEM-GenomeWeb … tomorrow at 12pm CST@QIAGENscience@QIAGEN@GenomeWeb@gizbab@StephensonCC@ouholterpic.twitter.com/fjWkNJ5frX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are top cancer centers implementing precision oncology? Our sister site
@PrecOncNews sought to find out with this survey:https://www.precisiononcologynews.com/cancer/survey-precision-oncology-programs-finds-agreement-testing-divergence-care-delivery …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb is hiring! We're looking for an experienced biopharma reporter for our new site, Precision Oncology News. More info here:https://www.linkedin.com/jobs/cap/view/1332917240/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Some diagnostic test kits marketed for home use are raising the eyebrows of lab experts worried about their safety to consumers and questioning whether they may be violating FDA regulations.https://www.360dx.com/immunoassays/home-tests-influenza-strep-others-raising-eyebrows-some-experts …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GenomeWeb proslijedio/la je Tweet
Register, today! Learn about the evidence supporting personal and clinical utility of polygenic risk profiling & how it can be transformative for clinical care as well as drug discovery. Register for this
@Illumina sponsored@GenomeWeb webinar here: https://bddy.me/2Feg1xX pic.twitter.com/doBwZrYqTv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.